SlideShare a Scribd company logo
1 of 11
Pharmaceutical Drugs    Industry By Zach Brewer, Joanna Schrank, Tracy Empson, Mark Lyubovitky ECON-200-002
Structure of the Industry ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Nature of Demand in the Industry ,[object Object]
How sensitive is the industry to changes in income? ,[object Object]
How sensitive is the industry to changes in income? ,[object Object],[object Object],[object Object]
Supply and Demand ,[object Object],[object Object]
Yummy Substitutes ,[object Object],[object Object]
Supply Factors ,[object Object],[object Object],[object Object],[object Object],[object Object]
Short and Long Term Cost ,[object Object],[object Object],[object Object],[object Object],[object Object]
Ability or Inability to Expand ,[object Object],[object Object],[object Object],[object Object],[object Object]
Entrance/Exit to and from Industry ,[object Object],[object Object]

More Related Content

What's hot

World castration resistant prostate cancer therapeutics - market
World castration resistant prostate cancer therapeutics - market   World castration resistant prostate cancer therapeutics - market
World castration resistant prostate cancer therapeutics - market
Allied Market Research
 
Pr healtherecare logitic
Pr healtherecare logiticPr healtherecare logitic
Pr healtherecare logitic
IMARC Group
 
HIGH COST OF CANCER DRUGS – PHARMA PERSPECTIVE
HIGH COST OF CANCER DRUGS – PHARMA PERSPECTIVEHIGH COST OF CANCER DRUGS – PHARMA PERSPECTIVE
HIGH COST OF CANCER DRUGS – PHARMA PERSPECTIVE
iData Insights
 
Emerging Biopharmaceutical Markets to Witness Exponential Growth
Emerging Biopharmaceutical Markets to Witness Exponential Growth Emerging Biopharmaceutical Markets to Witness Exponential Growth
Emerging Biopharmaceutical Markets to Witness Exponential Growth
IMARC Group
 

What's hot (20)

Synthetic Biology Market
Synthetic Biology MarketSynthetic Biology Market
Synthetic Biology Market
 
Cancer immunotherapies from the perspectives of oncology nurses
Cancer immunotherapies from the perspectives of oncology nursesCancer immunotherapies from the perspectives of oncology nurses
Cancer immunotherapies from the perspectives of oncology nurses
 
The Current Oncology Pipeline: Development & Launch
The Current Oncology Pipeline: Development & LaunchThe Current Oncology Pipeline: Development & Launch
The Current Oncology Pipeline: Development & Launch
 
Medical Syringe Market
Medical Syringe MarketMedical Syringe Market
Medical Syringe Market
 
Immuno oncology
Immuno oncologyImmuno oncology
Immuno oncology
 
Pharmaceutical Label Market Report: Trends, Forecast and Competitive Analysis
Pharmaceutical Label Market Report: Trends, Forecast and Competitive AnalysisPharmaceutical Label Market Report: Trends, Forecast and Competitive Analysis
Pharmaceutical Label Market Report: Trends, Forecast and Competitive Analysis
 
Respiratory devices market
Respiratory devices marketRespiratory devices market
Respiratory devices market
 
Biosimilars/Follow-on-Biologics Market
Biosimilars/Follow-on-Biologics Market Biosimilars/Follow-on-Biologics Market
Biosimilars/Follow-on-Biologics Market
 
World castration resistant prostate cancer therapeutics - market
World castration resistant prostate cancer therapeutics - market   World castration resistant prostate cancer therapeutics - market
World castration resistant prostate cancer therapeutics - market
 
Global biotechnology market
Global biotechnology market Global biotechnology market
Global biotechnology market
 
Dendreon Strategic Analysis
Dendreon Strategic AnalysisDendreon Strategic Analysis
Dendreon Strategic Analysis
 
Pr healtherecare logitic
Pr healtherecare logiticPr healtherecare logitic
Pr healtherecare logitic
 
Synthetic Biology Market Size, Share, Trend, Forecast, & Industry Analysis
Synthetic Biology Market Size, Share, Trend, Forecast, & Industry AnalysisSynthetic Biology Market Size, Share, Trend, Forecast, & Industry Analysis
Synthetic Biology Market Size, Share, Trend, Forecast, & Industry Analysis
 
Pharmaceutical economic ppt
Pharmaceutical economic pptPharmaceutical economic ppt
Pharmaceutical economic ppt
 
Biochemistry in UK
Biochemistry in UKBiochemistry in UK
Biochemistry in UK
 
Global Medical Oxygen Generator Market Production, Operations, Price and Gros...
Global Medical Oxygen Generator Market Production, Operations, Price and Gros...Global Medical Oxygen Generator Market Production, Operations, Price and Gros...
Global Medical Oxygen Generator Market Production, Operations, Price and Gros...
 
HIGH COST OF CANCER DRUGS – PHARMA PERSPECTIVE
HIGH COST OF CANCER DRUGS – PHARMA PERSPECTIVEHIGH COST OF CANCER DRUGS – PHARMA PERSPECTIVE
HIGH COST OF CANCER DRUGS – PHARMA PERSPECTIVE
 
Urinary Incontinence Treatment Drugs Market
Urinary Incontinence Treatment Drugs MarketUrinary Incontinence Treatment Drugs Market
Urinary Incontinence Treatment Drugs Market
 
Global spoolable pipe market
Global spoolable pipe marketGlobal spoolable pipe market
Global spoolable pipe market
 
Emerging Biopharmaceutical Markets to Witness Exponential Growth
Emerging Biopharmaceutical Markets to Witness Exponential Growth Emerging Biopharmaceutical Markets to Witness Exponential Growth
Emerging Biopharmaceutical Markets to Witness Exponential Growth
 

Viewers also liked

Germany 1939 40
Germany 1939 40Germany 1939 40
Germany 1939 40
popserge
 
Project4 Lecture
Project4 LectureProject4 Lecture
Project4 Lecture
rmyers131
 
Fbi executive report__dec_01_2010_issue_no_49_monitor
Fbi executive report__dec_01_2010_issue_no_49_monitorFbi executive report__dec_01_2010_issue_no_49_monitor
Fbi executive report__dec_01_2010_issue_no_49_monitor
HanyangFBI
 
Fbi executive report_sep_22_2010_issue_no_45_print
Fbi executive report_sep_22_2010_issue_no_45_printFbi executive report_sep_22_2010_issue_no_45_print
Fbi executive report_sep_22_2010_issue_no_45_print
HanyangFBI
 
Fbi executive report_ nov_03_2010_issue_no_47_monitor
Fbi executive report_ nov_03_2010_issue_no_47_monitorFbi executive report_ nov_03_2010_issue_no_47_monitor
Fbi executive report_ nov_03_2010_issue_no_47_monitor
HanyangFBI
 
Supplementary reading-material-in-economics-part-a-introductory-microeconomic...
Supplementary reading-material-in-economics-part-a-introductory-microeconomic...Supplementary reading-material-in-economics-part-a-introductory-microeconomic...
Supplementary reading-material-in-economics-part-a-introductory-microeconomic...
Bhishma Desai
 
F executive report__jan_12_2011_issue_no_50_monitor
F executive report__jan_12_2011_issue_no_50_monitorF executive report__jan_12_2011_issue_no_50_monitor
F executive report__jan_12_2011_issue_no_50_monitor
HanyangFBI
 
Fbi executive report_ nov_17_2010_issue_no_48_monitor
Fbi executive report_ nov_17_2010_issue_no_48_monitorFbi executive report_ nov_17_2010_issue_no_48_monitor
Fbi executive report_ nov_17_2010_issue_no_48_monitor
HanyangFBI
 
Fbi executive report_sep_22_2010_issue_no_45_monitor
Fbi executive report_sep_22_2010_issue_no_45_monitorFbi executive report_sep_22_2010_issue_no_45_monitor
Fbi executive report_sep_22_2010_issue_no_45_monitor
HanyangFBI
 

Viewers also liked (9)

Germany 1939 40
Germany 1939 40Germany 1939 40
Germany 1939 40
 
Project4 Lecture
Project4 LectureProject4 Lecture
Project4 Lecture
 
Fbi executive report__dec_01_2010_issue_no_49_monitor
Fbi executive report__dec_01_2010_issue_no_49_monitorFbi executive report__dec_01_2010_issue_no_49_monitor
Fbi executive report__dec_01_2010_issue_no_49_monitor
 
Fbi executive report_sep_22_2010_issue_no_45_print
Fbi executive report_sep_22_2010_issue_no_45_printFbi executive report_sep_22_2010_issue_no_45_print
Fbi executive report_sep_22_2010_issue_no_45_print
 
Fbi executive report_ nov_03_2010_issue_no_47_monitor
Fbi executive report_ nov_03_2010_issue_no_47_monitorFbi executive report_ nov_03_2010_issue_no_47_monitor
Fbi executive report_ nov_03_2010_issue_no_47_monitor
 
Supplementary reading-material-in-economics-part-a-introductory-microeconomic...
Supplementary reading-material-in-economics-part-a-introductory-microeconomic...Supplementary reading-material-in-economics-part-a-introductory-microeconomic...
Supplementary reading-material-in-economics-part-a-introductory-microeconomic...
 
F executive report__jan_12_2011_issue_no_50_monitor
F executive report__jan_12_2011_issue_no_50_monitorF executive report__jan_12_2011_issue_no_50_monitor
F executive report__jan_12_2011_issue_no_50_monitor
 
Fbi executive report_ nov_17_2010_issue_no_48_monitor
Fbi executive report_ nov_17_2010_issue_no_48_monitorFbi executive report_ nov_17_2010_issue_no_48_monitor
Fbi executive report_ nov_17_2010_issue_no_48_monitor
 
Fbi executive report_sep_22_2010_issue_no_45_monitor
Fbi executive report_sep_22_2010_issue_no_45_monitorFbi executive report_sep_22_2010_issue_no_45_monitor
Fbi executive report_sep_22_2010_issue_no_45_monitor
 

Similar to Pptmicroeconomics 100208131316-phpapp01

Antitrust Aspects of Acquiring a Generic Drug Manufacturer
Antitrust Aspects of Acquiring a Generic Drug ManufacturerAntitrust Aspects of Acquiring a Generic Drug Manufacturer
Antitrust Aspects of Acquiring a Generic Drug Manufacturer
Nexsen Pruet
 
Business Research Project-Report
Business Research Project-ReportBusiness Research Project-Report
Business Research Project-Report
Sharil Rose
 
Tw 1108035 stof_clintrials_rev_v1
Tw 1108035 stof_clintrials_rev_v1Tw 1108035 stof_clintrials_rev_v1
Tw 1108035 stof_clintrials_rev_v1
Helen Street
 
Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...
Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...
Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...
MedicineAndHealthUSA
 
Newtech advant-business-plan9
Newtech advant-business-plan9Newtech advant-business-plan9
Newtech advant-business-plan9
Yousaf Khan
 
Sector Analysis - Health Care
Sector Analysis - Health CareSector Analysis - Health Care
Sector Analysis - Health Care
Maisy Lam
 
Napm 2014 review
Napm 2014 reviewNapm 2014 review
Napm 2014 review
napmSA
 
pharma regulatory a
pharma regulatory apharma regulatory a
pharma regulatory a
swapy123
 

Similar to Pptmicroeconomics 100208131316-phpapp01 (20)

Are there reasons for believing that the profitability of the industry might ...
Are there reasons for believing that the profitability of the industry might ...Are there reasons for believing that the profitability of the industry might ...
Are there reasons for believing that the profitability of the industry might ...
 
Antitrust Aspects of Acquiring a Generic Drug Manufacturer
Antitrust Aspects of Acquiring a Generic Drug ManufacturerAntitrust Aspects of Acquiring a Generic Drug Manufacturer
Antitrust Aspects of Acquiring a Generic Drug Manufacturer
 
The future of pharma marketing
The future of pharma marketingThe future of pharma marketing
The future of pharma marketing
 
Business Research Project-Report
Business Research Project-ReportBusiness Research Project-Report
Business Research Project-Report
 
Tw 1108035 stof_clintrials_rev_v1
Tw 1108035 stof_clintrials_rev_v1Tw 1108035 stof_clintrials_rev_v1
Tw 1108035 stof_clintrials_rev_v1
 
Science As A Business
Science As A BusinessScience As A Business
Science As A Business
 
Supply chain in pharma sector
Supply chain in pharma sectorSupply chain in pharma sector
Supply chain in pharma sector
 
Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...
Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...
Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...
 
Big pharma-uncertain-future
Big pharma-uncertain-futureBig pharma-uncertain-future
Big pharma-uncertain-future
 
Newtech advant-business-plan9
Newtech advant-business-plan9Newtech advant-business-plan9
Newtech advant-business-plan9
 
Sector Analysis - Health Care
Sector Analysis - Health CareSector Analysis - Health Care
Sector Analysis - Health Care
 
BioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of BiotechBioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of Biotech
 
Final
FinalFinal
Final
 
Eli Lilly Global Strategy
Eli Lilly Global StrategyEli Lilly Global Strategy
Eli Lilly Global Strategy
 
Orphan Drug Report
Orphan Drug ReportOrphan Drug Report
Orphan Drug Report
 
Napm 2014 review
Napm 2014 reviewNapm 2014 review
Napm 2014 review
 
Porter five force model analysis of merck
Porter five force model analysis of merckPorter five force model analysis of merck
Porter five force model analysis of merck
 
biotech
biotechbiotech
biotech
 
pharma regulatory a
pharma regulatory apharma regulatory a
pharma regulatory a
 
Swapnil2
Swapnil2Swapnil2
Swapnil2
 

Pptmicroeconomics 100208131316-phpapp01

  • 1. Pharmaceutical Drugs Industry By Zach Brewer, Joanna Schrank, Tracy Empson, Mark Lyubovitky ECON-200-002
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.

Editor's Notes

  1. -Monopolistically competitive -Many sellers producing differentiated products -Firms engage in vertical/horizontal integration -Companies often specialize in product lines that deal with specific types of illnesses like cancer or central nervous system disorders -Johnson and Johnson -Founded in 1886 -Fortune 500 company -250+ subsidiary companies -Barron’s Magazine ranked it the world’s most respected company -Pfizer -Founded in 1849 -Best known for Lipitor and Lyrica -Shares made a part of the Dow Jones Industrial Average in 2004 -Bayer -Founded in 1863 -German Company -Best known for Bayer aspirin
  2. -Special features of the nature of demand in the pharmaceutical industry - Physician, not patient generally determines which drugs, and what quantity, are purchased - Demand is less elastic among people who are insured than among people who are not insured - Elasticity of demand also depends on whether or not there is a generic version of the drug
  3. -Sensitivity to changes in income depends on the type of pharmaceuticals - Drugs needed to treat more pressing medical conditions (like infections, diabetes, etc.) are not so sensitive to income - Drugs used for preventative care or less pressing medical conditions (high blood pressure, depression, etc.) are more sensitive to income because people don’t see them as necessities when they have less money to spend
  4. -“Many doctors and other experts say consumer belt-tightening is a big factor in the prescription downturn.” -” If enough people try to save money by forgoing drugs, controllable conditions could escalate into major medical problems. That could eventually raise the nation’s total health care bill and lower the nation’s standard of living.” -”With money tight, even cheaper generic drugs may not always be affordable drugs.”